Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 15/12/2019
SIETES contiene 92856 citas

 
 
<< anterior 21 a 40 de 435 siguiente >>
Presentar resultados
Seleccionar todas
21. Cita con resumen
Anónimo. Loxapine à inhaler. Un gadget plus dangereux qu'utile!. Prescrire 2014;34:894-5. [Ref.ID 98470]
22. Cita con resumen
Torniainen M, Mittendorfer-Rutz E, Tanskanen A, Björkenstam C, Suvisaari J, Alexanderson K, Tiihonen J. Antipsychotic treatment and mortality in schizophrenia. Schizophrenia Bulletin 2014:24 de noviembre. [Ref.ID 98382]
23.Tiene citas relacionadas Cita con resumen
McEvoy JP, Byerly M, Hamer RM, Dominik R, Swartz MS, Rosenheck RA, Ray N, Lamberti JS, Buckley PF, Wilkins TM, Stroup TS. Effectiveness of paliperidone vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA 2014;311:1978-87. [Ref.ID 97624]
25. Cita con resumen
Spielmans GI, Kirsch I. Drug approval and drug effectiveness. Annual Review of Clinical Psychology 2014;214:741-66. [Ref.ID 97582]
26.Tiene citas relacionadas Cita con resumen
Morrison AP, Turkington D, Pyle M, Spencer H, Brabban A, Dunn G, Christodoulides T, Dudley R, Chapman N, Callcott P, Grace T, Lumley V, Drage L, Tully S, Irving K, Cummings A, Byrne R, Davies LM, Hutton P. Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trial. Lancet 2014;383:1395-403. [Ref.ID 97498]
27.Tiene citas relacionadas Cita con resumen
Howes O. Cognitive therapy: at last an alternative to antipsychotics?. Lancet 2014;383:1364-6. [Ref.ID 97497]
28. Cita con resumen
Kuipers E, Yesufu-Udechuku A, Taylor C, Kendall T. Management of psychosis and schizophrenia in adults: summary of updated NICE guidance. BMJ 2014;348:g1173. [Ref.ID 97261]
29. Cita con resumen
Evins E, Cather C, Pratt SA, Pachas GN, Hoeppner SS, Goff DC, Achtyes ED, Ayer D, Schoenfeld DA. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trial . JAMA 2014;311:145-54. [Ref.ID 97036]
30.Tiene citas relacionadas
Leucht S, Cipriani A, Spineli L, Mavridis D, Örey D, Richter F, Samara M, Barbui C, Engel RR, Geddes JR, Kissling W, Stapf MP, Lässig B, Salanti G, Davis JM. Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis. Lancet 2013;382:951-62. [Ref.ID 96106]
31.Tiene citas relacionadas
Correli CU, De Hert M. Antipsychotics for acute schizophrenia: making choices. Lancet 2013;382:919-20. [Ref.ID 96104]
32.Enlace a cita original
George M, Amrutheshwar R, Rajkumar RP, Kattimani S, Dkhar SA. Newer antipsychotics and upcoming molecules for schizophrenia. Eur J Clin Pharmacol 2013;69:1497-509. [Ref.ID 95885]
33. Cita con resumen
Anónimo. Long-acting injectable aripiprazole (Ablify Maintena) for schizophrenia. Med Lett Drugs Ther 2013;55:34-6. [Ref.ID 95657]
34. Cita con resumen
Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?. Br J Clin Pharmacol 2013;75:323-33. [Ref.ID 94852]
35.
Kendall T, Hollis C, Stafford M, Taylor C, on behalf of the Guideline Development Group. Recognition and management of psychosis and schizophrenia in children and young people: summary of NICE guidance. BMJ 2013;346:34-7. [Ref.ID 94838]
36.Tiene citas relacionadas Cita con resumen
Stafford MR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ 2013;346:12. [Ref.ID 94829]
37.Tiene citas relacionadas
Van Os J, Murray RM. Can we prevent psychotic illness by treating "schizophrenia lite"?. BMJ 2013;346:9. [Ref.ID 94827]
38. Cita con resumen
Gili M, Roca M, Basu S, McKee M, Stuckler D. The mental health risks of economic crisis in Spain: evidence from primary care centres, 2006 and 2010. Eur J Public Health 2013;23:103-8. [Ref.ID 94645]
39.Enlace a cita original Cita con resumen
Moreno Izco L. Tratamiento antipsicótico ante el fracaso de la primera línea de tratamiento: ¿subir dosis, cambio de fármaco, asociar antipsicóticos?. Boletín de Información Farmacoterapéutica de Navarra 2012;20:1-11. [Ref.ID 94076]
40. Cita con resumen
Hartling L, Abou-Setta AM, Dursun S, Mousavi SS, Pasichnyk D, Newton AS. Antipsychotics in adults with schizophrenia: comparative effectiveness of first-generation versus second-generation medications: a systematic review and meta-analysis. Ann Intern Med 2012;157:498-511. [Ref.ID 93827]
Seleccionar todas
 
<< anterior 21 a 40 de 435 siguiente >>